Aptus Pharma Stock Screener | Share Price & Fundamental Analysis

Track Aptus Pharma share price live with TickJournal's free stock screener. Analyze Aptus Pharma share price history trends and compare 52-week high low levels. Calculate APPL stock fair value using fundamental analysis and view live share price charts. Determine Aptus Pharma share intrinsic value and compare it with current APPL share price. Record your Aptus Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Aptus Pharma Market Cap ₹169.09 Cr.
EPS (TTM) ₹6.37
Dividend Yield -
Debt to Equity 1.79
Aptus Pharma 52 Week Low -
Operating Margin -
Profit Margin -
EBITDA -
Net Income -
Total Assets ₹22.00
Total Equity ₹7.00

Aptus Pharma Share Price History - Stock Screener Chart

Screen APPL historical share price movements with interactive charts. Analyze price trends and patterns.

Aptus Pharma Company Profile - Fundamental Screener

Screen Aptus Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for APPL shares.
Sector Consumer Goods
Industry Household Appliances
Sub-Sector Household Appliances
Segment E
ISIN INE15XJ01010

Aptus Pharma Balance Sheet Screener

Screen APPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023
Assets
Total Assets 22 10 6
Current Assets 20 8 6
Fixed Assets 1 1 1
Liabilities
Total Liabilities 22 10 6
Current Liabilities 3 4 2
Non-Current Liabilities 0 0 0
Shareholders' Equity
Total Equity 7 2 1
Share Capital 5 0 0
Reserves & Surplus 2 2 1

Aptus Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Aptus Pharma income statement and profit fundamentals. Analyze APPL quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Aptus Pharma share price evaluation.
Item None-None 2025-March 2024-March 2023-March
Revenue 0 25 18 14
Expenses 0 20 16 13
EBITDA 0 5 2 1
Operating Profit % 0.00% 20.00% 9.00% 4.00%
Depreciation 0 0 0 0
Interest 0 1 0 0
Profit Before Tax 0 4 1 0
Tax 0 1 0 0
Net Profit 0 3 1 0
EPS 0.00 6.37 5.32 1.30

Aptus Pharma Cash Flow Screener - Liquidity Fundamentals

Screen APPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March
Operating Activities -2 -2 0
Investing Activities -1 0 0
Financing Activities 7 3 1
Net Cash Flow 4 0 0

Aptus Pharma Shareholding Pattern Screener

See Aptus Pharma shareholding pattern with promoter, FII, and DII holdings. Check Aptus Pharma promoter holding and ownership changes for APPL on TickJournal.
Item 2025-Jun 2025-Sept 2025-Dec
Promoter Holding 72.89% 72.89% 72.89%
FII Holding 10.03% 10.03% 0.00%
DII Holding 2.80% 2.80% 0.00%
Govt Holding 0.00% 0.00% 0.00%
Public Holding 11.55% 11.55% 22.97%
Other Holding 2.74% 2.74% 4.14%
Shareholder Count 9 9 302

Aptus Pharma Share Dividend Screener - Share Yield Analysis

Check Aptus Pharma dividend history with payout and yield data. View Aptus Pharma dividend details including ex-dates and amounts for APPL stock.
No dividends declared by Aptus Pharma.

Aptus Pharma Stock Index Membership

See which indices include Aptus Pharma stock. Check APPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Aptus Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Aptus Pharma Market Events Screener - Corporate Actions

Get Aptus Pharma corporate actions including splits, bonuses, and buybacks. Check Aptus Pharma stock events that may affect APPL share price.
Announcement Date Record Date Event Type Information Price Impact
2025-11-10 2025-11-10 Quarterly Result Announcement NA 12.62%

Aptus Pharma Competitors Screener - Peer Comparison

Screen APPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
LG Electronics 102,909 58.72 24,631 14.26% 2,203 55.90
Voltas 50,645 102.50 15,737 23.58% 834 65.81
Blue Star 40,617 83.08 12,043 23.73% 591 67.58
Amber Enterprises 27,332 148.56 10,047 48.08% 251 78.40
Crompton Greaves 17,557 36.48 7,932 7.48% 564 70.64
V-Guard Industries 14,153 49.28 5,599 14.48% 314 44.72
Whirlpool 11,396 34.05 8,110 15.97% 363 59.96
Eureka Forbes 10,179 62.19 2,452 11.53% 164 42.12
TTK Prestige 7,645 98.82 2,790 1.31% 108 38.47
Symphony 5,910 37.61 1,623 34.46% 213 40.23

Aptus Pharma Company Announcements - News Screener

Screen APPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-12 Announcement under Regulation 30 (LODR)-Investor Presentation View
2026-01-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-12-12 Press Release- Aptus Pharma Expands OTC Presence In Gujarat Strengthens Cosmeceutical Portfolio View
2025-11-21 Regulation 30 Disclosure - Entry Into The Urology Therapy Segment View
2025-11-12 Announcement under Regulation 30 (LODR)-Monitoring Agency Report View
2025-11-12 Intimation Of New Product- ENZYKING SYRUP View
2025-11-12 Intimation Of New Product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL) View
2025-11-11 Unaudited Financial Results For The Half Year Ended On 30Th September 2025 View
2025-11-10 Unaudited Financial Results For The Half Year Ended On 30Th September 2025 View
2025-11-10 Board Meeting Outcome for Board Meeting Outcome For Approval Of Unaudited Financial Results For The Half Year Ended On 30Th September 2025 View
2025-11-01 Board Meeting Intimation for To Consider And Take On Record Of The Un-Audited Financial Results For The Half Year Ended On 30Th September 2025. View
2025-10-21 Clarification On Price Movement View
2025-10-17 Clarification sought from Aptus Pharma Ltd -
2025-10-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View
2025-10-01 Closure of Trading Window View
2025-09-30 Listing of Equity Shares of Aptus Pharma Ltd -